Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031

Medartis Holding AG / Key word(s): Financing/Issue of Debt Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031 03-Apr-2024 / 17:43 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. PRESS RELEASE

Release of an ad hoc announcement pursuant to Art. 53 LR. The issuer is solely responsible for the content of this announcement.

Basel, 3 April 2024: Medartis Holding AG (SIX: MED, the “Company” or “Medartis”), a specialized orthopaedic company for head and extremity surgery, today announces the launch of a private placement offering (the “Offering”) of approx. CHF 115 million senior unsecured guaranteed convertible bonds due 2031 (the “Bonds”). The Bonds will be issued via the Company’s directly wholly-owned subsidiary, Medartis International Finance SAS (the “Issuer”), guaranteed by the Company and convertible into newly issued and/or existing registered shares of the Company. Advanced subscription rights for existing shareholders are excluded in the Offering.

Medartis intends to use the net proceeds of the  Bonds for general financing purposes, including acquisitions in its core business. The Bonds will be issued with a denomination of CHF 200,000 per bond at 100% of their principal amount. The Bonds are expected to carry a coupon of between 2.75% and 3.25% per annum, payable semi-annually in arrear, and will have a conversion price set at a premium of between 25% and 30% over the reference share price. The reference share price is expected to be equal to the placement price per Medartis share determined in the Concurrent Delta Placement (as further described below). Unless previously converted, redeemed or, repurchased and cancelled, the Bonds will be redeemed at 100% of their principal amount on the stated maturity date, which is expected to be on 11 April 2031. Advanced subscription rights for existing shareholders are excluded in the Offering.